Company news

Share this content:
Revolution Health and EmergingMed announced a partnership to offer a new cancer clinical trial matching service for patients and physicians. “EmergingMed is committed to providing personalized services to patients who are exploring treatment options,” said Courtney Hudson, EmergingMed founder and CEO in a statement. “We believe patients should have access to the latest research options targeting their specific diagnoses.” The service is available for online searching, as well as by telephone.
Share this content:
Scroll down to see the next article